Evotec Investor Day Presentation Deck
evotec
2021 (e)
Ill Bristol Myers Squibb
Ill Bristol Myers Squibb
lli Bristol Myers Squibb™
PAGE 26
iPSC-MS
iPSC-RD
INK - 10
y8 IT - 10
aß iT - 10
Pre-clinical
Clinical development
Strong portfolio emerging in CNS, 10, and metabolic diseases
Pipeline build-up to turn vision into reality in drug discovery & cell therapy
iM ¹) - 10
¡CM2) - CV
iSat³)
iPSC-Gaucher
QRbeta
THERAPEUTICS
QRbeta
THERAPEUTICS
1) Macrophages
2) Cardiomyocytes
3) Satellite cells muscle
4) Chondrocytes
2022/23 (e)
Ill Bristol Myers Squibb
Bristol Myers Squibb
INK - 10
78 IT - 10
aß iT - 10
iM - IO
INKT - 10
iDend - 10
iCM - CV
iSat - muscle
iNK - fibrosis
iChon 4) - OA
iPSC-Gaucher
QRbeta
THERAPEUTICS
iPSC-LSD
iPSC-ND
iPSC-MS
iPSC-Psych
Ill Bristol Myers Squibb
Bristol Myers Squibb
Bristol Myers Squibb
QRbeta
THERAPEUTICSView entire presentation